◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

CSOP Coinbase Daily (-2x) Inverse Product USD (7311) ETF Overview

Name: CSOP Coinbase Daily (-2x) Inverse Product USD (7311) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · DATA UPDATED 2026-09-22

CSOP Coinbase Daily (-2x) Inverse Product USD (7311) is an exchange-traded fund managed by CSOP Asset Management Limited. It manages roughly HK$2 million in assets.

Interactive chart & fund stats →

7311 Fund Statistics

Expense ratio	1.60%
Assets under management	HK$2 million
Fund family	CSOP Asset Management Limited
Inception	2025-03-21

The live price chart, fund profile and news are in the interactive 7311 viewer.

Other Companies in —

LQEU · LAIQON - European Equity AI Optimized Active UCITS ETF Acc — €2 million
AEXX · Amundi Euro stoxx UCITS ETF Dis — €2 million
EPIP · WisdomTree India Earnings UCITS ETF - USD Acc — £2 million
BCFL · UBS MSCI India Universal UCITS ETF USD Dis — €2 million
OSLU · Ossiam Lux - Ossiam SHILLER BARCLAYS CAPE US MARKET NEUTRAL UCITS ETF 1C USD — $2 million
PAUS · Invesco MSCI USA ESG Climate Paris Aligned UCITS ETF — €2 million
CSUC · Ninepoint Constellation Software CoreShares ETF — C$2 million
USFIN · Franklin S&P 500 Financials UCITS ETF USD Acc — €2 million

← 7309 All “0-9” companies 7313 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.